Disclosure of Securities Transactions
Disclosure of Securities Transactions by Members of the Supervisory Board and Board of Management
To comply with Section 15 a of the German Securities Trading Act, members of the Board of Management and Supervisory Board and their close relatives are required to disclose all transactions involving the purchase or sale of Bayer stock where such transactions total EUR 5,000 or more in a calendar year.
According to information filed with the company by members of the Board of Management and Supervisory Board, their total holdings of Bayer stock and related financial instruments amounted to less than 1 percent of the issued stock on the closing date for the financial statements.
According to information filed with the company by members of the Board of Management and Supervisory Board, their total holdings of Bayer stock and related financial instruments amounted to less than 1 percent of the issued stock on the closing date for the financial statements.
Transactions in the current fiscal year
So far this year no relevant reports have been filed by members of the Management Board and Supervisory Board of Bayer AG or their families.
Transactions in previous fiscal years
2007:
| Date/Place | Name | Function | Security | ISIN | Type of transaction | Price/ Currency |
Quantity | Total amount |
| March 29, 2007 Xetra |
Dr. Wolfgang Plischke | Management Board |
Share | DE0005752000 | Buy | € 47.70 | 5,300 | € 252,810.00 |
| January 10, 2007 Over the counter (Expiration date: May 23, 2008) |
Dr. Wolfgang Plischke | Management Board |
PROTECT-Discount-Share-Certificate (Underlying instrument: Share) |
FI: DE000SCL57K9 (Underlying instrument: DE0005752000) |
Buy | € 40.12 (Strike price: € 27.50 / Price multiplier: 1) |
350 | € 14,042.00 |
2006: No reportable securities transactions
2005: No reportable securities transactions
2005: No reportable securities transactions


Overview
Overview
Corporate Governance

Bookmark this page
E-mail this page
Board of Management


